Clinical impact of rapid oxacillin susceptibility testing using a PCR assay in Staphylococcus aureus bactaeremia

Journal of Infection

Volumn 39, Issue 3, 1999, Pages 198-204

  Allaouchiche, Bernard ^a   Jaumain, Hélène ^a   Zambardi, Gilles ^b   Chassard, Dominique ^a   Freney, Jean ^b  

^a HÔTEL DIEU   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OXACILLIN; PENICILLIN DERIVATIVE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS;

EID: 0033378980     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(99)90049-X     Document Type: Article

References (28)

1. Espersen F, Rosdahl V T. Frimodtmoller N, Skinhoj P. Epidemiology of Staphylococcus aureus bacteremia in Denmark. J Chemother 1994; 6: 219-225.
2. Espersen F. Identifying the patient risk for Staphylococcus aureus bloodstream infections. J Chemother 1995; 7: 11-17.
3. Mylotte J M, Aeschlimann J R, Rotella D L. Staphylococcus aureus bacteremia; Factors predicting hospital mortality. Infect Control Hosp Epidemiol 1996; 17: 165-168.
4. Arbo M D J, Snydman D R. Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med 1994; 154: 2641-2645.
5. Graninger W, Wenisch C, Hasenhundl M. Treatment of staphylococcal infections. Curr Opin Infect Dis 1995; 8: S20-S28.
6. Knapp C C, Ludwig M D, Washington J A. Evaluation of BBL crystal MRSA ID system. J Clin Microbiol 1994; 32: 2588-2589.
7. Knapp C C, Ludwig M D, Washington J A, Chambers H F. Evaluation of vitek GPS-SA card for testing of oxacillin against borderline-susceptible staphylococci that lack mec. J Clin Microbiol 1996; 34: 1603-1605.
8. Skulnick M, Simor A E, Patel M P, et al. Evaluation of three methods for the rapid identification of Staphylococcus aureus in blood cultures. Diagn Microbiol Infect Dis 1994; 19: 5-8.
9. Struelens M J, Nonhoff C, Vanderauwera P, Mertens R, Serruys E. Evaluation of Rapid ATB Staph for 5-hour antimicrobial susceptibility testing of Staphylococcus aureus. J Clin Microbiol 1995; 33: 2395-2399.
10. Zambardi G, Reverdy M E, Bland S, Bes M, Freney J, Fleurette J. Laboratory diagnosis of oxacillin resistance in Staphylococcus aureus by a multiplex- polymerase chain reaction assay. Diagn Microbiol Infect Dis 1994; 19: 25-31.
11. McCabe W R, Jackson G G, Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962; 110: 847-855.
12. National Committee of Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for clinical Laboratory Standards, 3rd edn. 1993: M7-A3.
13. National Committee of Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard. NCCLS document. National Committee for Clinical Laboratory Standards, 5th edn. 1993: M2-A5.
14. Goswitz J J, Willard K E, Fasching C E, Peterson L R. Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing. Antimicrob Agents Chemother 1992; 36: 1166-1169.
15. Murakami K, Minamide W, Wada K, Nakamura E, Teraoka H, Watanabe S. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991; 29: 2240-2244.
16. Tilton R C. The rapid detection of clinically significant bacteria. Adv Exp Med Biol 1990; 263: 111-114.
17. Trenholme G M, Kaplan R L, Karakusis P H, et al. Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J Clin Microbiol 1989; 27: 1342-1345.
18. Granato P A. The impact of same-day tests versus traditional overnight testing. Diagn Microbiol Infect Dis 1993; 16: 237-243.
19. Davis T E, Fuller D D. Direct identification of bacterial isolates in blood cultures by using a DNA probe. J Clin Microbiol 1991; 29: 2193-2196.
20. Jorgensen J H. Rapid methods in clinical microbiology. Clinical situations in which rapid methods may best be applied. Diagn Microbiol Infect Dis 1985; 3: 3S-7S.
21. Doern G V, Vautour R, Gaudet M, Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 1994; 32: 1757-1762.
22. Romerovivas J, Rubio M, Fernandez C, Picazo J J. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21: 1417-1423.
23. Hierholzer W J, Garner J S, Adams A B. et al. Recommendations for preventing the spread of vancomycin resistance: Recommendations of the hospital infection control practices advisory committee (HIC-PAC). Am J Infect Control 1995; 23: 87-94.
24. Kayser F H. Methicillin and glycopeptide resistance in staphylococci: A new threat? Curr Opin Infect Dis 1995; 8: S7-S11.
25. Edmond M B, Wenzel R P, Pasculle A W. Vancomycin-resistant Staphylococcus aureus: Perspectives on measures needed for control. Ann Intern Med 1996; 124: 329-334.
26. Mainardi J L, Shlaes D M, Goering R V, Shlaes J H, Acar J F, Goldstein F W. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J Infect Dis 1995; 171: 1646-1650.
27. Ploy M C, Grélaud C, Martin C, de Lumley L, Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a french hospital. Lancet 1998; 351: 1212.
28. Gruneberg R N, Wilson A P R. Anti-infective treatment in intensive care: the role of glycopeptides. Int Care Med 1994; 20: S17-S22.